| Pharmaceutical active ingredients: |
| Meprobamate |
| Available forms, composition and doses of Meprosa: |
| N / A |
| Meprosa medical category: |
| Human:Anxiolytics sedatives and hypnotics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N05BC01 - Meprobamate |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Meprocon | Carisoprodol | Unidentified Pharmaceutical Company |
| Meprodat | Carisoprodol | Unidentified Pharmaceutical Company |
| Meprol | Meprobamate | Unidentified Pharmaceutical Company |
| Meproleaf | Meprobamate | Unidentified Pharmaceutical Company |
| Mepronil | Meprobamate | Unidentified Pharmaceutical Company |
| Meprosan | Meprobamate | Unidentified Pharmaceutical Company |
| Meprosin | Meprobamate | Unidentified Pharmaceutical Company |
| Meprotabs | Meprobamate | Unidentified Pharmaceutical Company |
| Meprotan | Meprobamate | Unidentified Pharmaceutical Company |
| Meprotanum | Meprobamate | Unidentified Pharmaceutical Company |